Logo
x

Search

Subscribe Now

PTC Therapeutics

PTC Therapeutics Join Forces with Novartis to Develop PTC518 for Treating Huntington's Disease

PTC Therapeutics Join Forces with Novartis to Develop PTC518 for Treating Huntington's Disease

  • December 3, 2024
PTC Therapeutics Reports the US FDA’s Accelerated Approval of its Gene Therapy for AADC Deficiency

PTC Therapeutics Reports the US FDA’s Accelerated Approval of its Gene Therapy for AADC Deficiency

  • November 14, 2024
PharmaShots Weekly Snapshots (March 20 - 24, 2023)

PharmaShots Weekly Snapshots (March 20 - 24, 2023)

  • March 24, 2023
PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency

  • March 24, 2023
PharmaShots Weekly Snapshot (Aug 17 -21 2020)

PharmaShots Weekly Snapshot (Aug 17 -21 2020)

  • August 21, 2020
PharmaShots Weekly Snapshot (May 04-08, 2020)

PharmaShots Weekly Snapshot (May 04-08, 2020)

  • May 11, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.